ODDB.org: Open Drug Database

Vistide, Infusionskonzentrat - Ampulle(n)

Swissmedic Key	54310013	Registration Holder	Gilead Sciences Switzerland Sàrl
Name	Vistide, Infusionskonzentrat	Date of registration	12.11.1997
		Introduction of Sequence	12.11.1997
ATC-Classification	Cidofovir (J05AB12)	Revision date	27.10.2003
WHO	WHO-DDD	Valid until	18.06.2018
Index Therapeuticus (BSV)	08.03.	Show package size	Ampulle(n)
Index Therapeuticus (Swissmedic)	08.03.	Description	5 ml Ampulle à 375 mg
Swissmedic categorie.	A
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	980.30
Deductible	k.A.	Consumer price	1136.65
Feedback	FB	Daily cost
GTIN	7680543100134	Medication Code	Synthetika human
Pharmacode		Disponibility

Composition

cidofovirum 375 mg, aqua q.s. ad solutionem pro 5 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Active Agent	Dose
Cidofovir	375mg / 5ml

Source

Data was imported : 05.11.2013 Swissmedic Registration : 54310 Sequence : 01 Product name : Vistide, Infusionskonzentrat Registration owner: : Gilead Sciences Switzerland Sàrl Product group : Index Therapeuticus (BSV) : 08.03.0. Medication Code : Synthetika human Date of registration : 12.11.1997 Valid until : 18.06.2018 Package number : 013 Show package size : 1 Commercial Form/Unit : Ampulle(n) Swissmedic categorie. : A Active Agents : cidofovirum Composition : cidofovirum 375 mg, aqua q.s. ad solutionem pro 5 ml.

2025	©ywesee GmbH